42 related articles for article (PubMed ID: 1688763)
1. [A possible role of phosphoprotein p53 in the mechanism of autostimulation of tumor cell proliferation].
Ageenko AI; Erkhov VS; Cherniaev LV; Volkova LIu
Eksp Onkol; 1990; 12(1):35-7. PubMed ID: 1688763
[TBL] [Abstract][Full Text] [Related]
2. [Possible role of embryonic surface antigens in forming the autostimulus of tumor cell proliferation].
Erkhov VS; Ageenko AI
Eksp Onkol; 1986; 8(2):32-5. PubMed ID: 3698880
[TBL] [Abstract][Full Text] [Related]
3. [Two immunologically differing forms of p53 oncoprotein from B-lymphocytes of mice are coded with identical mRNA].
Chumakov PM; Jenkins JR; Milner R
Mol Gen Mikrobiol Virusol; 1989 Aug; (8):14-6. PubMed ID: 2478880
[TBL] [Abstract][Full Text] [Related]
4. Wild type human p53 is antiproliferative in SV40-transformed hamster cells.
Mercer WE; Amin M; Sauve GJ; Appella E; Ullrich SJ; Romano JW
Oncogene; 1990 Jul; 5(7):973-80. PubMed ID: 2165234
[TBL] [Abstract][Full Text] [Related]
5. The transformation-related p53 protein: a potential regulator of cell proliferation.
Mercer WE; Baserga R
Prog Clin Biol Res; 1985; 177():171-91. PubMed ID: 2409558
[No Abstract] [Full Text] [Related]
6. Cloning of the p53-dependent origin of cellular DNA replication.
Iguchi-Ariga SM; Okazaki T; Itani T; Ariga H
Oncogene; 1988 Nov; 3(5):509-15. PubMed ID: 2978868
[TBL] [Abstract][Full Text] [Related]
7. DNA binding properties of murine p53.
Steinmeyer K; Deppert W
Oncogene; 1988 Nov; 3(5):501-7. PubMed ID: 2978867
[TBL] [Abstract][Full Text] [Related]
8. Structural aspects of the p53 protein in relation to gene evolution.
Soussi T; Caron de Fromentel C; May P
Oncogene; 1990 Jul; 5(7):945-52. PubMed ID: 2142762
[No Abstract] [Full Text] [Related]
9. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell growth mediated by plasmids encoding p53 anti-sense.
Shohat O; Greenberg M; Reisman D; Oren M; Rotter V
Oncogene; 1987; 1(3):277-83. PubMed ID: 2455263
[TBL] [Abstract][Full Text] [Related]
11. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
Bartek J; Iggo R; Gannon J; Lane DP
Oncogene; 1990 Jun; 5(6):893-9. PubMed ID: 1694291
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
Romano JW; Ehrhart JC; Duthu A; Kim CM; Appella E; May P
Oncogene; 1989 Dec; 4(12):1483-8. PubMed ID: 2531855
[TBL] [Abstract][Full Text] [Related]
13. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein.
Milner J; Watson JV
Oncogene; 1990 Nov; 5(11):1683-90. PubMed ID: 2176282
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53 protein in tissues and organs of human and mouse embryo.
Lichnovský V; Kamarád V; Kolár Z; Vojtĕsek B
Acta Univ Palacki Olomuc Fac Med; 1994; 138():25-7. PubMed ID: 8714088
[TBL] [Abstract][Full Text] [Related]
15. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
Hansen S; Lane DP; Midgley CA
J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
[TBL] [Abstract][Full Text] [Related]
16. p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.
Stürzbecher HW; Maimets T; Chumakov P; Brain R; Addison C; Simanis V; Rudge K; Philp R; Grimaldi M; Court W
Oncogene; 1990 Jun; 5(6):795-81. PubMed ID: 2141683
[TBL] [Abstract][Full Text] [Related]
17. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
18. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
[TBL] [Abstract][Full Text] [Related]
19. Conformation changes of p53 proteins in regulation of murine T lymphocyte proliferation.
Wu J; Wang M; Li X; Sheng Y
Cell Mol Biol Res; 1993; 39(1):27-31. PubMed ID: 8287068
[TBL] [Abstract][Full Text] [Related]
20. Mouse cells with null p53 mutation have all p53 isoforms deleted and lose negative growth control.
Selkirk JK; He C; Merrick BA
Appl Theor Electrophor; 1994; 4(2):89-93. PubMed ID: 7880883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
